Paul C McGovern

6PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 28, 2026
Pharmacokinetics, safety, and tolerability of ceftibuten-ledaborbactam etzadroxil in participants with renal impairment.

|Apr 20, 2026
Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults.

|Aug 05, 2025
Safety and pharmacokinetics of single and multiple doses of ledaborbactam etzadroxil with or without ceftibuten in healthy volunteers.

Carlos Fernando de Oliveira, Mary Beth Dorr, Jeroen van de Wetering

|Aug 05, 2025
Pharmacokinetics and safety of single and repeat doses of ceftibuten in healthy participants: a phase 1 dose escalation study.

Mary Beth Dorr, Carlos Fernando de Oliveira, Jeroen van de Wetering

|May 23, 2024
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.

Greg Moeck, Leanne B Gasink, Rodrigo E Mendes

|Feb 14, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.

Florian M Wagenlehner, Leanne B Gasink, Paul C McGovern

Pageof 1

Frequent Collaborators

4 joint publications

Carlos Fernando de Oliveira

2 joint publications

Marc Engelhardt

2 joint publications

Kamal A Hamed

2 joint publications

Karine Litherland